Shopping Cart 0
Cart Subtotal
USD 0

Histocell SL - Product Pipeline Analysis, 2018 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2

Details

Summary

Histocell SL (Histocell), a subsidiary of Noray Biosciences Group, is a biopharmaceutical company that develops cell therapy and tissue engineering products for regenerative medicine. The company provides Wharton Gel Complex, medical devices, contract manufacturing and cell therapy programs, among others. Its wharton gel complex is a cosmetic ingredient with skin protective and regenerative properties. Histocell develops, manufactures and sells medical devices and drugs such as Cicatrigel, Histogel and Histobone, among others. The company also provides biocompatibility tests, advanced molecular and cellular biology analytical services and biological research services. Histocell is headquartered in Derio, Spain.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Histocell SL

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Histocell SL Company Overview 4

Histocell SL Company Snapshot 4

Histocell SL Pipeline Products and Ongoing Clinical Trials Overview 4

Histocell SL-Pipeline Analysis Overview 7

Histocell SL-Key Facts 7

Histocell SL-Major Products and Services 8

Histocell SL Pipeline Products by Development Stage 9

Histocell SL Pipeline Products Overview 12

Bioactive Wound Dressing 12

Bioactive Wound Dressing Product Overview 12

Biomaterial-Chronic Spinal Damage 13

Biomaterial-Chronic Spinal Damage Product Overview 13

Maxillofacial Implant 14

Maxillofacial Implant Product Overview 14

Peripheral Nerve Implant 15

Peripheral Nerve Implant Product Overview 15

Protein Based Bio-Scaffolds 16

Protein Based Bio-Scaffolds Product Overview 16

Reoxcare 17

Reoxcare Product Overview 17

Scaffold Regeneration-Oral Masticatory Mucosa Injuries 18

Scaffold Regeneration-Oral Masticatory Mucosa Injuries Product Overview 18

Histocell SL-Key Competitors 19

Histocell SL-Key Employees 20

Histocell SL-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Joint Venture 21

Recent Developments 22

Histocell SL, Recent Developments 22

Mar 12, 2018: Histocell takes Part with Great Success in the 7th Seher Congress 22

Sep 26, 2017: Histocell and VITALVIA collaborate to promote the commercialisation in Spain of the new product for wound healing Reoxcare 22

Jun 20, 2016: Reoxcare: Luqa's innovative wound dressing product, obtains CE mark in Europe 22

Appendix 24

Methodology 24

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

Histocell SL Pipeline Products by Equipment Type 5

Histocell SL Pipeline Products by Development Stage 9


List Of Table

List of Tables

Histocell SL Pipeline Products and Ongoing Clinical Trials Overview 4

Histocell SL Pipeline Products by Equipment Type 5

Histocell SL Pipeline Products by Indication 6

Histocell SL, Key Facts 7

Histocell SL, Major Products and Services 8

Histocell SL Number of Pipeline Products by Development Stage 9

Histocell SL Pipeline Products Summary by Development Stage 10

Bioactive Wound Dressing-Product Status 12

Bioactive Wound Dressing-Product Description 12

Biomaterial-Chronic Spinal Damage-Product Status 13

Biomaterial-Chronic Spinal Damage-Product Description 13

Maxillofacial Implant-Product Status 14

Maxillofacial Implant-Product Description 14

Peripheral Nerve Implant-Product Status 15

Peripheral Nerve Implant-Product Description 15

Protein Based Bio-Scaffolds-Product Status 16

Protein Based Bio-Scaffolds-Product Description 16

Reoxcare-Product Status 17

Reoxcare-Product Description 17

Scaffold Regeneration-Oral Masticatory Mucosa Injuries-Product Status 18

Scaffold Regeneration-Oral Masticatory Mucosa Injuries-Product Description 18

Histocell SL, Key Employees 20

Histocell SL, Joint Venture 21

Glossary 26

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Histocell SL, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Centro Andaluz de Biologia Molecular y Medicina Regenerativa

Genetrix SL

ERA Biotech SA

Fina Biotech SL

BBD BioPhenix SL

Company Profile

Company Profile Title

Summary

Histocell SL (Histocell), a subsidiary of Noray Biosciences Group, is a biopharmaceutical company that develops cell therapy and tissue engineering products for regenerative medicine. The company provides Wharton Gel Complex, medical devices, contract manufacturing and cell therapy programs, among others. Its wharton gel complex is a cosmetic ingredient with skin protective and regenerative properties. Histocell develops, manufactures and sells medical devices and drugs such as Cicatrigel, Histogel and Histobone, among others. The company also provides biocompatibility tests, advanced molecular and cellular biology analytical services and biological research services. Histocell is headquartered in Derio, Spain.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Histocell SL

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Histocell SL Company Overview 4

Histocell SL Company Snapshot 4

Histocell SL Pipeline Products and Ongoing Clinical Trials Overview 4

Histocell SL-Pipeline Analysis Overview 7

Histocell SL-Key Facts 7

Histocell SL-Major Products and Services 8

Histocell SL Pipeline Products by Development Stage 9

Histocell SL Pipeline Products Overview 12

Bioactive Wound Dressing 12

Bioactive Wound Dressing Product Overview 12

Biomaterial-Chronic Spinal Damage 13

Biomaterial-Chronic Spinal Damage Product Overview 13

Maxillofacial Implant 14

Maxillofacial Implant Product Overview 14

Peripheral Nerve Implant 15

Peripheral Nerve Implant Product Overview 15

Protein Based Bio-Scaffolds 16

Protein Based Bio-Scaffolds Product Overview 16

Reoxcare 17

Reoxcare Product Overview 17

Scaffold Regeneration-Oral Masticatory Mucosa Injuries 18

Scaffold Regeneration-Oral Masticatory Mucosa Injuries Product Overview 18

Histocell SL-Key Competitors 19

Histocell SL-Key Employees 20

Histocell SL-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Joint Venture 21

Recent Developments 22

Histocell SL, Recent Developments 22

Mar 12, 2018: Histocell takes Part with Great Success in the 7th Seher Congress 22

Sep 26, 2017: Histocell and VITALVIA collaborate to promote the commercialisation in Spain of the new product for wound healing Reoxcare 22

Jun 20, 2016: Reoxcare: Luqa's innovative wound dressing product, obtains CE mark in Europe 22

Appendix 24

Methodology 24

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

Histocell SL Pipeline Products by Equipment Type 5

Histocell SL Pipeline Products by Development Stage 9


List Of Table

List of Tables

Histocell SL Pipeline Products and Ongoing Clinical Trials Overview 4

Histocell SL Pipeline Products by Equipment Type 5

Histocell SL Pipeline Products by Indication 6

Histocell SL, Key Facts 7

Histocell SL, Major Products and Services 8

Histocell SL Number of Pipeline Products by Development Stage 9

Histocell SL Pipeline Products Summary by Development Stage 10

Bioactive Wound Dressing-Product Status 12

Bioactive Wound Dressing-Product Description 12

Biomaterial-Chronic Spinal Damage-Product Status 13

Biomaterial-Chronic Spinal Damage-Product Description 13

Maxillofacial Implant-Product Status 14

Maxillofacial Implant-Product Description 14

Peripheral Nerve Implant-Product Status 15

Peripheral Nerve Implant-Product Description 15

Protein Based Bio-Scaffolds-Product Status 16

Protein Based Bio-Scaffolds-Product Description 16

Reoxcare-Product Status 17

Reoxcare-Product Description 17

Scaffold Regeneration-Oral Masticatory Mucosa Injuries-Product Status 18

Scaffold Regeneration-Oral Masticatory Mucosa Injuries-Product Description 18

Histocell SL, Key Employees 20

Histocell SL, Joint Venture 21

Glossary 26

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Histocell SL, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Centro Andaluz de Biologia Molecular y Medicina Regenerativa

Genetrix SL

ERA Biotech SA

Fina Biotech SL

BBD BioPhenix SL